ToxSci Advance Access originally published online on July 27, 2005
Toxicological Sciences 2005 87(2):316-321; doi:10.1093/toxsci/kfi270
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FORUM SERIES |
Research Strategies for Safety Evaluation of Nanomaterials, Part I: Evaluating the Human Health Implications of Exposure to Nanoscale Materials

* ILSI Health and Environmental Sciences Institute, One Thomas Circle, NW, 9th Floor, Washington, District of Columbia 20005 and
Office of Pollution Prevention and Toxics, U. S. Environmental Protection Agency, 1200 Pennsylvania Ave, NW (MC 7403M), Washington, District of Columbia 20460
Received May 16, 2005; accepted July 18, 2005
Nanotechnology has the potential to dramatically improve the effectiveness of a number of existing consumer and industrial products and could have a substantial impact on the development of new products ranging from disease diagnosis and treatment to environmental remediation. The broad range of possible nanotechnology applications could lead to substantive changes in industrial productivity, economic growth, and international trade. A continuing evaluation of the human health implications of exposure to nanoscale materials will be essential before the commercial benefits of these materials can be fully realized. The purpose of this article is to review the human health implications of exposure to nanoscale materials in the context of a toxicological risk evaluation, the current scope of U.S. Federal research on nanoscale materials, and selected toxicological studies associated with nanoscale materials to note emerging research in this area.
Key Words: nanomaterials; nanoscale materials; nanotechnology; risk assessment; toxicology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Lison, L. C. J. Thomassen, V. Rabolli, L. Gonzalez, D. Napierska, J. W. Seo, M. Kirsch-Volders, P. Hoet, C. E. A. Kirschhock, and J. A. Martens Nominal and Effective Dosimetry of Silica Nanoparticles in Cytotoxicity Assays Toxicol. Sci., July 1, 2008; 104(1): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Holsapple, W. H. Farland, T. D. Landry, N. A. Monteiro-Riviere, J. M. Carter, N. J. Walker, and K. V. Thomas Research Strategies for Safety Evaluation of Nanomaterials, Part II: Toxicological and Safety Evaluation of Nanomaterials, Current Challenges and Data Needs Toxicol. Sci., November 1, 2005; 88(1): 12 - 17. [Abstract] [Full Text] [PDF] |
||||
